The surgical and visual outcomes of 25-gauge vitrectorhexis in paediatric cataract surgery with in-the-bag IOL implantation

Session Details

Session Title: Paediatric Cataract Surgery

Session Date/Time: Sunday 15/09/2019 | 16:30-18:00

Paper Time: 17:30

Venue: Free Paper Forum: Podium 2

First Author: : R.Anjum INDIA

Co Author(s): :    U. Raina   S. Chaudhary   S. Gupta   J. Goyal   P. Sharma   V. Saini              

Abstract Details

Purpose:

To assess the visual and surgical outcome of anterior continuous curvilinear capsulorhexis (ACCC) and posterior continuous curvilinear capsulorhexis (PCCC) capsulorhexis by 25 gauge(G) vitrectorhexis in pediatric cataract surgery with in the bag IOL implantation.

Setting:

It was a prospective interventional study conducted at Guru Nanak Eye Centre, Maulana Azad Medical College, New Delhi, India.

Methods:

A total of 15 eyes of children of age group 3 to 8 years with zonular cataract were selected for ACCC and PCCC by 25G vitrectomy cutter (vitrectorhexis) with IOL implantation. At 3 months postoperatively, best corrected visual acuity (BCVA) and visual axis opacification (VAO) were evaluated. Slitlamp photos of operated eyes were taken in retroillumination, the size and decentration of ACCC and PCCC were measured from the center of IOL were measured with the help of python imaging library.

Results:

At 3 months postoperatively, the mean BCVA was 0.56±0.07 ( visual acuity in decimals), mean average diameter (average of horizontal and vertical diameters) of ACCC diameter was 4.89±0.41 millimeters (mm) and the mean average diameter (average of horizontal and vertical diameters) of PCCC was 3.28±0.45 (mm). The mean decentration of ACCC and PCCC from the centre of IOL at the end of 3 months were 0.24 mm and 0.28 mm respectively. VAO was 0.00%.

Conclusions:

25G vitrectorhexis gives adequate visual outcome with adequate sized ACCC and PCCC, with no extension of rhexis, with minimal decentration of ACCC and PCCC from the centre of IOL and no significant VAO in pediatric cataract surgery.

Financial Disclosure:

None